#USA #Singapore #Emerald Clinical #Glenn Kerkhof #Mary Gunn

Emerald Clinical Trials Announces Leadership Change

Emerald Clinical Trials, a leading global organization in clinical research, has confirmed a pivotal change in its leadership team. Effective immediately, Mary Gunn has stepped down from her position as CEO. In her place, the board has appointed Glenn Kerkhof as the interim CEO, a long-standing board member with extensive experience in contract research organizations (CROs). This transition indicates a proactive approach to maintain continuity and ensure the organization's stability and performance during this period of change.

Sean Carney, the board's chairman, expressed gratitude for Mary Gunn's contributions during her tenure, highlighting her role in guiding the company through various challenges. "Emerald Clinical Trials is a premier CRO with global capabilities, and with Glenn taking the reigns as interim CEO, we believe we can continue to keep pace and meet our commitments to our clients," Carney stated.

Glenn Kerkhof brings over 30 years of experience in clinical research and pharmaceutical services. He previously served as CEO of Chiltern, where he successfully led the company to significant international expansion. Additionally, Kerkhof was the executive chairman at George Clinical, now known as Emerald Clinical Trials, where he played a critical role in shaping the company's growth in Asia.

"The strengths of Emerald Clinical Trials lie in our therapeutic focus, scientific depth, and close collaboration with clients," said Kerkhof. He emphasized the importance of a smooth transition, trustworthy client commitments, and supporting global teams. Kerkhof is committed to building on the company's dynamism and leading with clear goals and determination during this transition.

About Emerald Clinical Trials

Emerald Clinical Trials is a leading organization in the clinical research sector, operating on a global scale and providing services to over 100 biotechnology firms and six of the top ten major pharmaceutical companies. Headquartered in Singapore, the company leverages operational expertise and scientific excellence to deliver comprehensive clinical trial services to clients worldwide. They offer solutions for all stages of studies, underscoring their commitment to advancing healthcare through rigorous research. For more information, visit www.emeraldclinical.com.